Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity.

about

Electrophysiological and neuromuscular stability of persons with chronic inflammatory demyelinating polyneuropathy.IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety.

P2860

Q48133654-87232678-E8BC-4364-AD7F-F2AAB8918888 Q49299297-D0067237-0C70-4182-ABEF-7425B6F69A88

P2860

Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity.

Item

http://www.wikidata.org/entity/Q41002811

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel Therapeutic Avenues for ...... iculties of Disease Diversity.

@en

type

Item

label

Novel Therapeutic Avenues for ...... iculties of Disease Diversity.

@en

prefLabel

Novel Therapeutic Avenues for ...... iculties of Disease Diversity.

@en

P1476

Novel Therapeutic Avenues for ...... iculties of Disease Diversity.

@en

P2093

Yusuf A Rajabally

http://www.w3.org/2001/XMLSchema#string

P2860

Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.

Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.

Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.

Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population.

Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

P304

12-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2016.03.026

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299128343

http://www.w3.org/2001/XMLSchema#string

P698

27211536

http://www.w3.org/2001/XMLSchema#string

P932

4856771

http://www.w3.org/2001/XMLSchema#string

Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity.

about

P2860

P2860

Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932